Overview
Therese Mulvey is a Hematologist Oncology specialist and a Hematologist in Fall River, Massachusetts. Dr. Mulvey is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Breast Cancer in Men, and Angiosarcoma. Dr. Mulvey is currently accepting new patients.
Her clinical research consists of co-authoring 37 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
The General Hospital Corporation
Lecia Sequist is an Oncologist and a Hematologist in Waltham, Massachusetts. Dr. Sequist is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Sequist is currently accepting new patients.
The General Hospital Corporation
Justin Gainor is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Gainor is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and EGFR Positive Lung Cancer. Dr. Gainor is currently accepting new patients.
Rhode Island Hospital
Christopher Azzoli is an Oncologist and a Hematologist in Providence, Rhode Island. Dr. Azzoli is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Mulvey isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Mulvey isDistinguished. Learn about Breast Cancer.
- Breast Cancer in MenDr. Mulvey isDistinguished. Learn about Breast Cancer in Men.
- Inflammatory Breast CancerDr. Mulvey isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Mulvey isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Colorectal CancerDr. Mulvey isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Mulvey isAdvanced. Learn about Familial Colorectal Cancer.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Mulvey isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Caffey DiseaseDr. Mulvey isExperienced. Learn about Caffey Disease.
- DehydrationDr. Mulvey isExperienced. Learn about Dehydration.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Mulvey isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- EGFR Positive Lung CancerDr. Mulvey isExperienced. Learn about EGFR Positive Lung Cancer.
- Familial Pancreatic CancerDr. Mulvey isExperienced. Learn about Familial Pancreatic Cancer.